September 27, 2023
You are here:  Home  >  Banking & Finance  >  Current Article

Sientra wins new FDA approval


The U.S. Food and Drug Administration approved a new breast implant on July 6 made by Goleta-based Sientra.

Sientra’s Low Plus Profile Projection Breast Implant will be commercially available to plastic surgeons in the United States in late July, the company said in a news release. It is for cosmetic surgery for women at least 22 years old, and for women of all ages undergoing breast reconstruction.

With this approval, Sientra will be the only implant maker within the United States to offer 80cc and 110cc gel implants, which are smaller than most implants.

Sientra shares closed at 85 cents on July 6, down 3.3% for the day. They are down nearly 90% in the past year.